Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4065 USD | -5.47% | -14.76% | -7.59% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 2.57M | Capitalization | 21.46M |
---|---|---|---|---|---|
Net income 2024 * | -27M | Net income 2025 * | -28M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 8.35 x |
P/E ratio 2024 * |
-0.8
x | P/E ratio 2025 * |
-0.91
x | Employees | 27 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.01% |
Latest transcript on AIM ImmunoTech Inc.
1 day | -5.47% | ||
1 week | -14.76% | ||
Current month | -13.69% | ||
1 month | -7.61% | ||
3 months | -2.05% | ||
6 months | -3.44% | ||
Current year | -7.59% |
Managers | Title | Age | Since |
---|---|---|---|
Thomas Equels
CEO | Chief Executive Officer | 71 | 08-11-16 |
Robert Dickey
DFI | Director of Finance/CFO | 68 | 22-04-03 |
Chief Tech/Sci/R&D Officer | - | 22-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nancy K. Bryan
BRD | Director/Board Member | 66 | 23-03-27 |
William Mitchell
CHM | Chairman | 89 | 98-06-30 |
Thomas Equels
CEO | Chief Executive Officer | 71 | 08-11-16 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 0.4065 | -5.47% | 341,694 |
24-04-24 | 0.43 | +1.06% | 160,867 |
24-04-23 | 0.4255 | +1.31% | 256,717 |
24-04-22 | 0.42 | -9.68% | 169,268 |
24-04-19 | 0.465 | -2.50% | 78,182 |
Delayed Quote Nyse, April 25, 2024 at 04:10 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.59% | 21.46M | |
-2.26% | 104B | |
+1.41% | 97.42B | |
+0.79% | 22.2B | |
-17.84% | 21.23B | |
-11.11% | 18.33B | |
-42.83% | 16.35B | |
-17.63% | 15.06B | |
+4.55% | 13.98B | |
+32.11% | 11.66B |
- Stock Market
- Equities
- AIM Stock